ArticleDiabetology & metabolic syndrome2020
Metabolic syndrome amongst adults in Jordan: prevalence, trend, and its association with socio-demographic characteristics.
Article in Diabetology & metabolic syndrome, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Cross-Cultural Perspectives on Metabolic Syndrome Management and Attitudes Toward Using Digital Health Tools in Two Distinct Populations: Protocol for a Qualitative Descriptive Study.JMIR research protocols · 2026Article
- Associations of sociodemographic factors and lifestyle behaviors with the risk of cardiometabolic disease: a population-based study from the European health interview survey in Hungary.BMC public health · 2026Article
- Knowledge and awareness of insulin resistance among social media users: A cross-sectional study in Jordan.Journal of education and health promotion · 2026Article
- Metabolic syndrome among adults aged 18-40 years in the United Arab Emirates: prevalence and associated factors using harmonized criteria.Frontiers in public health · 2026Article
- Lipid-adiposity indices outperform traditional and derived anthropometric and biochemical indices for discriminating individuals with metabolic syndrome.Frontiers in endocrinology · 2026Article
- Trends in the prevalence of metabolic syndrome among Jordanian adults following COVID-19.Therapeutic advances in endocrinology and metabolism · 2026Article
- Evaluating body composition, the eating behavior scale, and the healthy lifestyle index in female Jordanian adults with metabolic syndrome: a cross-sectional study.Diabetology & metabolic syndrome · 2025Article
- A nationwide comparative analysis of the prevalance and determinants of non-communicable diseases risk factors between Jordanian and displaced Syrian populations.BMC public health · 2025Observational
- The Prevalence of Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes in Jordan: The PACT-MEA Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025Article
- 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.Circulation · 2025Review
- Article
- Sex differences in prevalence of metabolic syndrome components and contributing factors among psychiatric patients in Saudi Arabia.Frontiers in public health · 2025Article
- Depressive symptom trajectories and incident metabolic syndrome in middle-aged and older adults: A longitudinal analysis of the ELSA study.Frontiers in psychiatry · 2025Article
- Metabolic syndrome prediction based on body composition indices.The Journal of the Egyptian Public Health Association · 2024Article
- 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.Circulation · 2024Review
- Prevalence and associated factors of non-communicable chronic diseases among university academics in Jordan.PloS one · 2024Article
- Sex-Specific Cut-Offs of Seven Adiposity Indicators and Their Performance in Predicting Metabolic Syndrome in Arab Adults.Journal of clinical medicine · 2023Article
- Strengthening Primary Healthcare in Jordan for Achieving Universal Health Coverage: A Need for Family Health Team Approach.Healthcare (Basel, Switzerland) · 2023Article
- Profiling Cardiometabolic Health in Jordan: A Call to Action to Improve Cardiovascular Health.Cureus · 2023Review
- Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.Circulation · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultiple epidemiological studies were conducted amongst a variety of ethnic groups and showed discrepancies in the prevalence of metabolic syndrome (MeS) and its individual components. This study aimed to determine the prevalence of MeS in Jordan using both the Adult Treatment Panel Guidelines (ATP III) and the International Diabetes Federation (IDF) criteria. The study also aimed to assess the changes in the prevalence of MeS over time and determine its association with sociodemographic variables.
methodsData from the 2017 Cardiovascular Disease Risk Factors Survey were used for this study. Socio-demographic and clinical data were collected using a structured questionnaire. Blood samples were taken for biochemical measurements. Furthermore, anthropometric characteristics were measured by the same team of trained field researchers. A sample of 4,056 individuals aged between 18 and 90 years was included in this study. The findings from the 2017 survey were compared with the findings of a 2009 survey that adopted the same methods and procedures.
resultsAccording to the IDF criteria, the crude prevalence of Metabolic syndrome was 48.2% (52.9% among men and 46.2% among women; p < 0.001). Using the ATP III criteria, the prevalence was 44.1% (51.4% among men and 41% among women, p < 0.001). The age-standardized prevalence rate of metabolic syndrome was 44% (95% CI 42.7, 45.4) and 39.9% (95% CI 39.6, 41.2), according to both the IDF definition and ATP III criteria, respectively. The Kappa measure of agreement showed excellent agreement between the two definitions (k = 81.9%, p < 0.001). Of all participants, 41.7% met both the IDF and ATP III diagnostic criteria, 6.6% met the IDF criteria only, and 2.5% met the ATP III criteria only. The age-standardized prevalence rate of metabolic syndrome was significantly higher in 2017 (45.7% in men and 44.5% in women) than that in 2009 survey (34.6% in men and 39.8% in women). Gender, age, occupation, region, and marital status were significantly associated with metabolic syndrome.
conclusionsThe prevalence of metabolic syndrome in Jordan is considerably high and it is increasing. Healthy lifestyle programs encouraging appropriate dietary habits and physical activity are strongly recommended in Jordan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.